 | Up a level |
Journal Article
Ghofrani, Hossein-Ardeschir, Grimminger, Friedrich 
ORCID: 0000-0001-8725-6276, Gruenig, Ekkehard, Huang, Yigao, Jansa, Pavel ORCID: 0000-0002-3711-7064, Jing, Zhi-Cheng ORCID: 0000-0003-0493-0929, Kilpatrick, David, Langleben, David, Rosenkranz, Stephan, Menezes, Flavia, Fritsch, Arno, Nikkho, Sylvia and Humbert, Marc ORCID: 0000-0003-0703-2892
(2016).
Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial.
Lancet Resp. Med., 4 (5).
S. 361 - 372.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2213-2600
Richter, Manuel J., Harutyunova, Satenik, Bollmann, Tom, Classen, Simon, Gall, Henning, Gerhardt, Felix, Grimminger, Friedrich, Grimminger, Jan, Gruenig, Ekkehard, Guth, Stefan, Halank, Michael, Heine, Alexander, Hoeper, Marius M., Klose, Hans, Lange, Tobias J., Meyer, Katrin, Neurohr, Claus, Nickolaus, Kai, Olsson, Karen M., Opitz, Christian F., Rosenkranz, Stephan, Seyfarth, Hans-Juergen, Warnke, Christian, Wiedenroth, Christoph, Ghofrani, Hossein A. and Ewert, Ralf (2018). Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension. J. Heart Lung Transplant., 37 (10). S. 1235 - 1245. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1557-3117